Remission and Progression-Free Survival in Patients With Newly Diagnosed Multiple Myeloma Treated With Carfilzomib, Lenalidomide, and Dexamethasone: Five-Year Follow-up of a Phase 2 Clinical Trial

Dickran Kazandjian, Neha Korde, Sham Mailankody, Elizabeth Hill, William D. Figg, Mark Roschewski, Ola Landgren

Research output: Contribution to journalLetterpeer-review

21 Scopus citations
Original languageEnglish (US)
Pages (from-to)1781-1783
Number of pages3
JournalJAMA Oncology
Volume4
Issue number12
DOIs
StatePublished - Dec 2018
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this